Insider Transactions in Q3 2017 at Eli Lilly & CO (LLY)
Insider Transaction List (Q3 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2017
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.08%
|
$16,575,000
$85.29 P/Share
|
|
Sep 18
2017
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
132
+0.36%
|
$10,824
$82.52 P/Share
|
|
Sep 18
2017
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+3.72%
|
$9,594
$82.52 P/Share
|
|
Sep 15
2017
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
190,000
-0.08%
|
$15,580,000
$82.91 P/Share
|
|
Aug 31
2017
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
180,000
-0.15%
|
$14,580,000
$81.06 P/Share
|
|
Aug 21
2017
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
141
+0.38%
|
$10,857
$77.38 P/Share
|
|
Aug 21
2017
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
125
+4.14%
|
$9,625
$77.38 P/Share
|
|
Jul 31
2017
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
220,000
-0.09%
|
$18,260,000
$83.38 P/Share
|
|
Jul 17
2017
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
131
+0.36%
|
$10,873
$83.64 P/Share
|
|
Jul 17
2017
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
116
+4.02%
|
$9,628
$83.64 P/Share
|